Literature DB >> 22102480

Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery.

Baocheng Tian1, Qiuhua Luo, Shuangshuang Song, Dandan Liu, Hao Pan, Wenji Zhang, Ling He, Shilin Ma, Xinggang Yang, Weisan Pan.   

Abstract

The objective of this study was to propose novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan (NLC-PDSC) as an efficient ocular delivery system to improve its transcorneal penetration and precorneal retention. PDSC with a deacetylation degree of around 50% was synthesized using an improved method. NLC loaded with flurbiprofen (FB) were prepared by melt emulsification method. They presented spherical morphology under both transmission electron microscope and scanning electron microscope. After coating with 0.15% (w/v) PDSC solution, the NLC showed a core-shell structure and a reversed zeta potential. The enhanced transcorneal penetration of the coated NLC was evaluated using isolated rabbit corneas, with significantly increased apparent permeability coefficient being 1.40- and 1.75-fold of the NLC and FB phosphate solution (FB-sol; p < 0.05), respectively. Precorneal retention assessed by gamma scintigraphy in vivo showed that the area under the remaining activity-time curve of the PDSC-coated formulation was 1.3-fold of the NLC and 2.4-fold of FB-sol. Moreover, in vivo ocular tolerance study indicated that there was no difference in irritation between the coated and noncoated NLC. In conclusion, novel NLC demonstrate high potential for ocular drug delivery.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22102480     DOI: 10.1002/jps.22813

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Identification and Testing of Novel CARP-1 Functional Mimetic Compounds as Inhibitors of Non-Small Cell Lung and Triple Negative Breast Cancers.

Authors:  Magesh Muthu; Jaganmohan Somagoni; Vino T Cheriyan; Sara Munie; Edi Levi; Abdelkader E Ashour; Alaa Eldeen B Yassin; Ahmed M Alafeefy; Paula Sochacki; Lisa A Polin; Kaladhar B Reddy; Scott D Larsen; Mandip Singh; Arun K Rishi
Journal:  J Biomed Nanotechnol       Date:  2015-09       Impact factor: 4.099

Review 2.  Nanoparticles for drug delivery to the anterior segment of the eye.

Authors:  Dileep R Janagam; Linfeng Wu; Tao L Lowe
Journal:  Adv Drug Deliv Rev       Date:  2017-04-06       Impact factor: 15.470

3.  Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.

Authors:  Dandan Liu; Jinyu Li; Hao Pan; Fengwei He; Zhidong Liu; Qingyin Wu; Chunping Bai; Shihui Yu; Xinggang Yang
Journal:  Sci Rep       Date:  2016-06-28       Impact factor: 4.379

Review 4.  Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds.

Authors:  Malihe Sadat Razavi; Pedram Ebrahimnejad; Yousef Fatahi; Antony D'Emanuele; Rassoul Dinarvand
Journal:  Front Chem       Date:  2022-04-13       Impact factor: 5.545

5.  Effective Ocular Delivery of Eplerenone Using Nanoengineered Lipid Carriers in Rabbit Model.

Authors:  Eman Abdelhakeem; Mohamed El-Nabarawi; Rehab Shamma
Journal:  Int J Nanomedicine       Date:  2021-07-22

6.  Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functions.

Authors:  Wenji Zhang; Xuedong Li; Tiantian Ye; Fen Chen; Shihui Yu; Jianting Chen; Xinggang Yang; Na Yang; Jinsong Zhang; Jinlu Liu; Weisan Pan; Jun Kong
Journal:  Int J Nanomedicine       Date:  2014-09-11

7.  CARP-1 functional mimetics are novel inhibitors of drug-resistant triple negative breast cancers.

Authors:  Vino T Cheriyan; Magesh Muthu; Ketan Patel; Sreeja Sekhar; Walajapet Rajeswaran; Scott D Larsen; Lisa Polin; Edi Levi; Mandip Singh; Arun K Rishi
Journal:  Oncotarget       Date:  2016-11-08

Review 8.  Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review.

Authors:  Mohamed Haider; Shifaa M Abdin; Leena Kamal; Gorka Orive
Journal:  Pharmaceutics       Date:  2020-03-23       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.